Human papilloma virus genotyping for the cross-sectional and longitudinal probability of developing cervical intraepithelial neoplasia grade 2 or more: HPV genotyping for risk stratification

This study was supported by Ministero della Salute (Progetto Speciale“Valutazione di nuove tecnologie per lo screening del cervicocarcinoma –follow-up” and L 138–2004 progetto “NTCC—Nuove tecnologie per loscreening del cervicocarcinoma”), by FP7 Health (CoHeahr project, FP7grant agreement no. HEALTH-F3–2013–603019) and by the AssociazioneItaliana per la Ricerca sul Cancro (AIRC, Project IG14119). Research fund-ing was also obtained from Qiagen, BD, Abbott, Hologic, Trovagene, Onco-health, Genera and Cepheid (to J.C.).